{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:51:53Z","timestamp":1793263913819,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007721","name":"Cure SMA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41589-019-0384-5","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T12:51:05Z","timestamp":1571662265000},"page":"1191-1198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["Structural basis of a small molecule targeting RNA for a specific splicing correction"],"prefix":"10.1038","volume":"15","author":[{"given":"S\u00e9bastien","family":"Campagne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Boigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"R\u00fcdisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Moursy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Gillioz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kn\u00f6rlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasane","family":"Ratni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Cl\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2131-6237","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric H.-T.","family":"Allain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"384_CR1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(80)90847-8","volume":"1","author":"J Pearn","year":"1980","unstructured":"Pearn, J. Classification of spinal muscular atrophies. Lancet 1, 919\u2013922 (1980).","journal-title":"Lancet"},{"key":"384_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0955-0674(02)00332-0","volume":"14","author":"S Paushkin","year":"2002","unstructured":"Paushkin, S., Gubitz, A. K., Massenet, S. & Dreyfuss, G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr. Opin. Cell Biol. 14, 305\u2013312 (2002).","journal-title":"Curr. Opin. Cell Biol."},{"key":"384_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s004390100473","volume":"108","author":"CF Rochette","year":"2001","unstructured":"Rochette, C. F., Gilbert, N. & Simard, L. R. SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum. Genet. 108, 255\u2013266 (2001).","journal-title":"Hum. Genet."},{"key":"384_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni, L. & Krainer, A. R. Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30, 377\u2013384 (2002).","journal-title":"Nat. Genet."},{"key":"384_CR5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","volume":"34","author":"T Kashima","year":"2003","unstructured":"Kashima, T. & Manley, J. L. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet. 34, 460\u2013463 (2003).","journal-title":"Nat. Genet."},{"key":"384_CR6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes, A. H. & Beattie, C. E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat. Rev. Neurosci. 10, 597\u2013609 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"384_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","volume":"4","author":"MD Mailman","year":"2002","unstructured":"Mailman, M. D. et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet. Med. 4, 20\u201326 (2002).","journal-title":"Genet. Med."},{"key":"384_CR8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/sj.mt.6300200","volume":"15","author":"J Marquis","year":"2007","unstructured":"Marquis, J. et al. Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence. Mol. Ther. 15, 1479\u20131486 (2007).","journal-title":"Mol. Ther."},{"key":"384_CR9","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pbio.0050073","volume":"5","author":"Y Hua","year":"2007","unstructured":"Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F. & Krainer, A. R. Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol. 5, e73 (2007).","journal-title":"PLoS Biol."},{"key":"384_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11168","volume":"7","author":"ME Rogalska","year":"2016","unstructured":"Rogalska, M. E. et al. Therapeutic activity of modified U1 core spliceosomal particles. Nat. Commun. 7, 11168 (2016).","journal-title":"Nat. Commun."},{"key":"384_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04110-1","volume":"9","author":"A Garcia-Lopez","year":"2018","unstructured":"Garcia-Lopez, A. et al. Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes. Nat. Commun. 9, 2032 (2018).","journal-title":"Nat. Commun."},{"key":"384_CR12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","volume":"345","author":"NA Naryshkin","year":"2014","unstructured":"Naryshkin, N. A. et al. Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy. Science 345, 688\u2013693 (2014).","journal-title":"Science"},{"key":"384_CR13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","volume":"11","author":"J Palacino","year":"2015","unstructured":"Palacino, J. et al. SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice. Nat. Chem. Biol. 11, 511\u2013517 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"384_CR14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua, Y. et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 478, 123\u2013126 (2011).","journal-title":"Nature"},{"key":"384_CR15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F. & Krainer, A. R. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am. J. Hum. Genet. 82, 834\u2013848 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"384_CR16","doi-asserted-by":"crossref","first-page":"e25736","DOI":"10.7554\/eLife.25736","volume":"6","author":"I Beusch","year":"2017","unstructured":"Beusch, I., Barraud, P., Moursy, A., Clery, A. & Allain, F. H. Tandem hnRNP A1 RNA recognition motifs act in concert to repress the splicing of survival motor neuron exon 7. Elife 6, e25736 (2017).","journal-title":"Elife"},{"key":"384_CR17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0883073815627882","volume":"31","author":"M Hache","year":"2016","unstructured":"Hache, M. et al. Intrathecal injections in children with spinal muscular atrophy: nusinersen clinical trial experience. J. Child Neurol. 31, 899\u2013906 (2016).","journal-title":"J. Child Neurol."},{"key":"384_CR18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust, K. D. et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat. Biotechnol. 28, 271\u2013274 (2010).","journal-title":"Nat. Biotechnol."},{"key":"384_CR19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1126\/science.1258444","volume":"345","author":"L Vigevani","year":"2014","unstructured":"Vigevani, L. & Valcarcel, J. A splicing magic bullet. Science 345, 624\u2013625 (2014).","journal-title":"Science"},{"key":"384_CR20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrd4445","volume":"13","author":"M Cully","year":"2014","unstructured":"Cully, M. Neuromuscular disorders: beefing up the right splice variant to treat spinal muscular atrophy. Nat. Rev. Drug Discov. 13, 725 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"384_CR21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"384_CR22","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.25011\/cim.v41i1.29461","volume":"41","author":"R Schneider","year":"2018","unstructured":"Schneider, R. CIM Journal Club: gene therapy for spinal muscular atrophy Comment on Mendell et al. N Engl J Med 2017;377:1713-22. Clin. Invest. Med. 41, E31\u2013E33 (2018).","journal-title":"Clin. Invest. Med."},{"key":"384_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bcp.13786","volume":"85","author":"S Sturm","year":"2019","unstructured":"Sturm, S. et al. A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier. Br. J. Clin. Pharm. 85, 181\u2013193 (2019).","journal-title":"Br. J. Clin. Pharm."},{"key":"384_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01559-4","volume":"8","author":"M Sivaramakrishnan","year":"2017","unstructured":"Sivaramakrishnan, M. et al. Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers. Nat. Commun. 8, 1476 (2017).","journal-title":"Nat. Commun."},{"key":"384_CR25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nsmb.2001","volume":"18","author":"A Clery","year":"2011","unstructured":"Clery, A. et al. Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-beta1. Nat. Struct. Mol. Biol. 18, 443\u2013450 (2011).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"384_CR26","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1093\/nar\/gku244","volume":"42","author":"A Moursy","year":"2014","unstructured":"Moursy, A., Allain, F. H. & Clery, A. Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation. Nucleic Acids Res. 42, 6659\u20136672 (2014).","journal-title":"Nucleic Acids Res."},{"key":"384_CR27","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/hmg\/11.17.2037","volume":"11","author":"Y Hofmann","year":"2002","unstructured":"Hofmann, Y. & Wirth, B. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1. Hum. Mol. Genet. 11, 2037\u20132049 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"384_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/11.5.577","volume":"11","author":"PJ Young","year":"2002","unstructured":"Young, P. J. et al. SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1. Hum. Mol. Genet. 11, 577\u2013587 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"384_CR29","doi-asserted-by":"crossref","first-page":"E4604","DOI":"10.1073\/pnas.1800260115","volume":"115","author":"J Wang","year":"2018","unstructured":"Wang, J., Schultz, P. G. & Johnson, K. A. Mechanistic studies of a small-molecule modulator of SMN2 splicing. Proc. Natl Acad. Sci. USA 115, E4604\u2013E4612 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"384_CR30","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","volume":"61","author":"H Ratni","year":"2018","unstructured":"Ratni, H. et al. Discovery of risdiplam, a selective survival of motor Neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA). J. Med. Chem. 61, 6501\u20136517 (2018).","journal-title":"J. Med. Chem."},{"key":"384_CR31","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acs.jmedchem.7b00406","volume":"60","author":"E Pinard","year":"2017","unstructured":"Pinard, E. et al. Discovery of a novel class of survival motor neuron 2 splicing modifiers for the treatment of spinal muscular atrophy. J. Med. Chem. 60, 4444\u20134457 (2017).","journal-title":"J. Med. Chem."},{"key":"384_CR32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature07851","volume":"458","author":"DA Pomeranz Krummel","year":"2009","unstructured":"Pomeranz Krummel, D. A., Oubridge, C., Leung, A. K., Li, J. & Nagai, K. Crystal structure of human spliceosomal U1 snRNP at 5.5 \u00c5 resolution. Nature 458, 475\u2013480 (2009).","journal-title":"Nature"},{"key":"384_CR33","doi-asserted-by":"crossref","first-page":"e04986","DOI":"10.7554\/eLife.04986","volume":"4","author":"Y Kondo","year":"2015","unstructured":"Kondo, Y., Oubridge, C., van Roon, A. M. & Nagai, K. Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5\u02b9 splice site recognition. Elife 4, e04986 (2015).","journal-title":"Elife"},{"key":"384_CR34","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1101\/gad.190173.112","volume":"26","author":"X Roca","year":"2012","unstructured":"Roca, X. et al. Widespread recognition of 5\u02b9 splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides. Genes Dev. 26, 1098\u20131109 (2012).","journal-title":"Genes Dev."},{"key":"384_CR35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nsmb.1546","volume":"16","author":"X Roca","year":"2009","unstructured":"Roca, X. & Krainer, A. R. Recognition of atypical 5\u02b9 splice sites by shifted base-pairing to U1 snRNA. Nat. Struct. Mol. Biol. 16, 176\u2013182 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"384_CR36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/nyas.12727","volume":"1341","author":"NN Singh","year":"2015","unstructured":"Singh, N. N., Lee, B. M. & Singh, R. N. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions. Ann. NY Acad. Sci. 1341, 176\u2013187 (2015).","journal-title":"Ann. NY Acad. Sci."},{"key":"384_CR37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/nar\/gkl1050","volume":"35","author":"NN Singh","year":"2007","unstructured":"Singh, N. N., Singh, R. N. & Androphy, E. J. Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res. 35, 371\u2013389 (2007).","journal-title":"Nucleic Acids Res."},{"key":"384_CR38","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1261\/rna.5175703","volume":"9","author":"BM Rhode","year":"2003","unstructured":"Rhode, B. M., Hartmuth, K., Urlaub, H. & Luhrmann, R. Analysis of site-specific protein\u2013RNA cross-links in isolated RNP complexes, combining affinity selection and mass spectrometry. RNA 9, 1542\u20131551 (2003).","journal-title":"RNA"},{"key":"384_CR39","doi-asserted-by":"crossref","first-page":"e1003106","DOI":"10.1371\/journal.pcbi.1003106","volume":"9","author":"MI Stefan","year":"2013","unstructured":"Stefan, M. I. & Le Novere, N. Cooperative binding. PLoS Comput. Biol. 9, e1003106 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"384_CR40","first-page":"187","volume":"33","author":"FJ Ehlert","year":"1988","unstructured":"Ehlert, F. J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharm. 33, 187\u2013194 (1988).","journal-title":"Mol. Pharm."},{"key":"384_CR41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/pr.54.2.323","volume":"54","author":"A Christopoulos","year":"2002","unstructured":"Christopoulos, A. & Kenakin, T. G protein-coupled receptor allosterism and complexing. Pharm. Rev. 54, 323\u2013374 (2002).","journal-title":"Pharm. Rev."},{"key":"384_CR42","doi-asserted-by":"crossref","first-page":"e0174706","DOI":"10.1371\/journal.pone.0174706","volume":"12","author":"JM Jansen","year":"2017","unstructured":"Jansen, J. M. et al. Inhibition of prenylated KRAS in a lipid environment. PLoS One 12, e0174706 (2017).","journal-title":"PLoS One"},{"key":"384_CR43","doi-asserted-by":"crossref","first-page":"13737","DOI":"10.1073\/pnas.0907195106","volume":"106","author":"GG Hammes","year":"2009","unstructured":"Hammes, G. G., Chang, Y. C. & Oas, T. G. Conformational selection or induced fit: a flux description of reaction mechanism. Proc. Natl Acad. Sci. USA 106, 13737\u201313741 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"384_CR44","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T","volume":"15","author":"M Krawczak","year":"2000","unstructured":"Krawczak, M. et al. Human gene mutation database\u2014a biomedical information and research resource. Hum. Mutat. 15, 45\u201351 (2000).","journal-title":"Hum. Mutat."},{"key":"384_CR45","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3837","volume":"49","author":"R Soemedi","year":"2017","unstructured":"Soemedi, R. et al. Pathogenic variants that alter protein code often disrupt splicing. Nat. Genet. 49, 848\u2013855 (2017).","journal-title":"Nat. Genet."},{"key":"384_CR46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nchembio1208-723","volume":"4","author":"MD Disney","year":"2008","unstructured":"Disney, M. D. Short-circuiting RNA splicing. Nat. Chem. Biol. 4, 723\u2013724 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"384_CR47","doi-asserted-by":"crossref","first-page":"33147","DOI":"10.1074\/jbc.M805556200","volume":"283","author":"K O\u2019Brien","year":"2008","unstructured":"O\u2019Brien, K., Matlin, A. J., Lowell, A. M. & Moore, M. J. The biflavonoid isoginkgetin is a general inhibitor of pre-mRNA splicing. J. Biol. Chem. 283, 33147\u201333154 (2008).","journal-title":"J. Biol. Chem."},{"key":"384_CR48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2018.03.011","volume":"70","author":"C Cretu","year":"2018","unstructured":"Cretu, C. et al. Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds. Mol. Cell 70, 265\u2013273.e8 (2018).","journal-title":"Mol. Cell"},{"key":"384_CR49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.aax3289","volume":"364","author":"C Charenton","year":"2019","unstructured":"Charenton, C., Wilkinson, M. E. & Nagai, K. Mechanism of 5\u02b9 splice site transfer for human spliceosome activation. Science 364, 362\u2013367 (2019).","journal-title":"Science"},{"key":"384_CR50","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1021\/acs.jmedchem.6b00459","volume":"59","author":"H Ratni","year":"2016","unstructured":"Ratni, H. et al. Specific correction of alternative survival motor neuron 2 splicing by small molecules: discovery of a potential novel medicine to treat spinal muscular atrophy. J. Med. Chem. 59, 6086\u20136100 (2016).","journal-title":"J. Med. Chem."},{"key":"384_CR51","unstructured":"Keller, R. The Computer-Aaided Resonance Assignment Tutorial. (Cantina Verlag, 2004)."},{"key":"384_CR52","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1021\/ci700172n","volume":"47","author":"Y Binev","year":"2007","unstructured":"Binev, Y., Marques, M. M. & Aires-de-Sousa, J. Prediction of 1H NMR coupling constants with associative neural networks trained for chemical shifts. J. Chem. Inf. Model. 47, 2089\u20132097 (2007).","journal-title":"J. Chem. Inf. Model."},{"key":"384_CR53","first-page":"353","volume":"278","author":"P Guntert","year":"2004","unstructured":"Guntert, P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353\u2013378 (2004).","journal-title":"Methods Mol. Biol."},{"key":"384_CR54","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case, D. A. et al. The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668\u20131688 (2005).","journal-title":"J. Comput. Chem."},{"key":"384_CR55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41589-019-0384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-019-0384-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41589-019-0384-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:28:12Z","timestamp":1684607292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-019-0384-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1038\/s41589-019-0384-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736788685.793576918","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.R. is an employee of F. Hoffmann-La Roche Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}